Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Relistor Injection Generic Name & Formulations
Legal Class
Rx
General Description
Methylnaltrexone bromide 8mg/0.4mL, 12mg/0.6mL; soln for SC inj.
Pharmacological Class
Opioid antagonist (peripheral).
See Also
How Supplied
Tabs—60, 90; Single-use vial (12mg/0.6mL)—1; Prefilled syringes (8mg/0.4mL)—7; Prefilled syringes (12mg/0.6mL)—1, 7
Manufacturer
Generic Availability
NO
Relistor Injection Indications
Indications
Opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including chronic pain related to prior cancer or its treatment in patients who do not require frequent opioid dosage escalation. OIC in adults with advanced illness or pain caused by active cancer who require opioid dosage escalation for palliative care.
Limitations of Use
Use for >4 months has not been studied in the advanced illness population.
Relistor Injection Dosage and Administration
Adult
Give by SC inj in upper arm, abdomen, or thigh; rotate inj sites. Chronic non-cancer pain: Discontinue all maintenance laxatives prior to initiation; may be used if suboptimal methylnaltrexone response after 3 days. Reevaluate if opioid regimen is changed. Give 12mg once daily. Advanced illness: Give once every other day as needed (max 1 dose/24hrs). <38kg or >114kg: 0.15mg/kg. 38–<62kg: 8mg. 62–114kg: 12mg. Moderate or severe renal impairment (CrCl<60mL/min): reduce dose by ½ (see full labeling). Severe hepatic impairment: may consider reducing weight-based dose by ½ (non-cancer pain only). Prefilled syringes: use only for 8mg or 12mg fixed doses.
Children
Not established.
Relistor Injection Contraindications
Contraindications
Known or suspected GI obstruction and at increased risk of recurrent obstruction.
Relistor Injection Boxed Warnings
Not Applicable
Relistor Injection Warnings/Precautions
Warnings/Precautions
Discontinue if concurrent opioid pain medication is also discontinued. GI perforation; monitor for severe, persistent, or worsening abdominal pain; discontinue if occurs. Discontinue if severe or persistent diarrhea occurs. Increased risk of opioid withdrawal and/or reduced analgesia in those with blood-brain barrier disruptions; monitor for symptoms. Bowel movement may occur within 30 mins of dosing. Elderly. Pregnancy. Nursing mothers: not recommended.
Relistor Injection Pharmacokinetics
See Literature
Relistor Injection Interactions
Interactions
Potential additive effects and increased risk of opioid withdrawal with concomitant other opioid antagonists; avoid.
Relistor Injection Adverse Reactions
Adverse Reactions
Abdominal pain, flatulence, nausea, dizziness, diarrhea, headache, abdominal distention, vomiting, hyperhidrosis, anxiety, muscle spasms, rhinorrhea, chills, tremor, hot flush; GI perforation, opioid withdrawal.
Relistor Injection Clinical Trials
See Literature
Relistor Injection Note
Not Applicable
Relistor Injection Patient Counseling
See Literature
Images
